Symptomatic Non Obstructive Hypertrophic Cardiomyopathy clinical trials

Explore recruiting symptomatic non obstructive hypertrophic cardiomyopathy clinical trials.

Recruiting symptomatic non obstructive hypertrophic cardiomyopathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Symptomatic Non Obstructive Hypertrophic Cardiomyopathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Global Phase 2b, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients with Symptomatic Non Obstructive Hypertrophic Cardiomyopathy – FORTITUDE-HCM

Austria, Germany, Belgium, France, Portugal, Spain +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Multi-Center, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Poland, Spain, Italy, Hungary, France, Germany +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Symptomatic Non Obstructive Hypertrophic Cardiomyopathy trials by city

Symptomatic Non Obstructive Hypertrophic Cardiomyopathy in Toronto Symptomatic Non Obstructive Hypertrophic Cardiomyopathy in Vancouver Symptomatic Non Obstructive Hypertrophic Cardiomyopathy in Montreal Symptomatic Non Obstructive Hypertrophic Cardiomyopathy in Calgary Symptomatic Non Obstructive Hypertrophic Cardiomyopathy in Edmonton Symptomatic Non Obstructive Hypertrophic Cardiomyopathy in Ottawa Symptomatic Non Obstructive Hypertrophic Cardiomyopathy in Winnipeg Symptomatic Non Obstructive Hypertrophic Cardiomyopathy in Quebec City Symptomatic Non Obstructive Hypertrophic Cardiomyopathy in Hamilton Symptomatic Non Obstructive Hypertrophic Cardiomyopathy in Kitchener Symptomatic Non Obstructive Hypertrophic Cardiomyopathy in London Symptomatic Non Obstructive Hypertrophic Cardiomyopathy in Halifax Symptomatic Non Obstructive Hypertrophic Cardiomyopathy in New York Symptomatic Non Obstructive Hypertrophic Cardiomyopathy in Los Angeles Symptomatic Non Obstructive Hypertrophic Cardiomyopathy in Chicago Symptomatic Non Obstructive Hypertrophic Cardiomyopathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease